APA (7th ed.) Citation

CY, W., W, A., BR, S., MK, K., JD, E., CJ, M., & W, S. (2025). Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: A population-based cohort study. Alzheimer's research & therapy, 17(1), 269. https://doi.org/10.1186/s13195-025-01929-x

Chicago Style (17th ed.) Citation

CY, Wu, Alkabbani W, Shah BR, Kapral MK, Edwards JD, Maxwell CJ, and Swardfager W. "Comparative Dementia Risk with GLP1 Receptor Agonists, SGLT2 Inhibitors, or DPP4 Inhibitors: A Population-based Cohort Study." Alzheimer's Research & Therapy 17, no. 1 (2025): 269. https://doi.org/10.1186/s13195-025-01929-x.

MLA (9th ed.) Citation

CY, Wu, et al. "Comparative Dementia Risk with GLP1 Receptor Agonists, SGLT2 Inhibitors, or DPP4 Inhibitors: A Population-based Cohort Study." Alzheimer's Research & Therapy, vol. 17, no. 1, 2025, p. 269, https://doi.org/10.1186/s13195-025-01929-x.